Matthew Barber, MD
Orthopaedic Surgery · Mobile, ALNPI 1346338647
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $103,013 of the $158,128 with a category attached, or 65.1%. 37 manufacturers reported payments, led by Intellijoint Surgical Inc. at 32.7% of the total. 2025 is the largest year on record at $42,148, 2.7 times the $15,894 reported in 2019. Among orthopaedic surgery clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 195 payments — averaging $810.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intellijoint Surgical Inc.$52K
- UOC USA Inc$32K
- Ortho Development Corporation$28K
- Think Surgical, Inc.$16K
- Conformis, Inc.$14K
- Heron Therapeutics, Inc.$7K
- plus $9K from 31 others
Across 8 payments — averaging $2300.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Conformis, Inc.$18K
Across 4 payments — averaging $3450.00 each. An ownership or investment interest held by the physician or an immediate family member.
- Adcura, Inc.$14K
What the payments were for
- Royalty or licence$18,81512%
- Consulting fees$103,01365%
- Speaking & faculty fees$17,11811%
- Travel & lodging$14,0429%
- Food & beverage$5,1403%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intellijoint Surgical Inc. | 5 | $51,650 |
| UOC USA Inc | 24 | $31,514 |
| Ortho Development Corporation | 40 | $27,602 |
| Think Surgical, Inc. | 12 | $16,496 |
| Conformis, Inc. | 19 | $14,188 |
| Heron Therapeutics, Inc. | 5 | $7,183 |
| Globus Medical | 11 | $3,672 |
| Medacta USA, Inc. | 12 | $2,998 |
| Smith+Nephew | 16 | $1,053 |
| Restor3d, Inc. | 3 | $454 |
| Stryker | 2 | $189 |
| Johnson & Johnson | 3 | $148 |
| Amgen(2 entities) | 8 | $105 |
| Boston Scientific | 3 | $82 |
| Prime Surgical, LLC | 1 | $78 |
| Medical Device Business Services, Inc. | 1 | $71 |
| Convatec Inc. | 2 | $69 |
| Zimvie Inc. | 3 | $63 |
| Kowa Pharmaceuticals America, Inc. | 4 | $62 |
| Kyocera Medical Technologies, Inc. | 1 | $45 |
| Zimmer Biomet | 2 | $40 |
| Bioventus LLC | 2 | $40 |
| Sanofi-aventis U.S. LLC | 2 | $35 |
| Relievant Medsystems, Inc. | 1 | $31 |
| Kerecis Limited | 1 | $27 |
| Maxx Orthopedics, Inc. | 1 | $26 |
| DJO, LLC | 1 | $26 |
| BD | 1 | $24 |
| Vertex | 1 | $23 |
| Si-bone, Inc. | 1 | $22 |
| Engage Uni, LLC | 1 | $20 |
| Ferring Pharmaceuticals Inc. | 1 | $19 |
| Pacira Therapeutics, Inc. | 1 | $18 |
| Avanos Medical | 1 | $15 |
| Trice Medical, Inc. | 1 | $14 |
| Pacira Pharmaceuticals Incorporated | 1 | $13 |
| Onkos Surgical, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intellijoint HIP$28,900
- Intelljoint$22,750
- BKS TriMax$17,853
- Tsolution One Surgical System$14,211
- U2 PSI$11,097
- U2, PSA, U-Star II$10,763
- Zynrelef$7,100
- PSI$7,051
- iTotal$5,600
- Hip Stem III$5,530
- Balanced Knee System$4,908
- TMINI Miniature Robotic System$2,014
- Balance Knee Revision System$1,625
- Cones$1,575
- Alpine Hip System$1,541
- Hip$1,507
- GMK SPHERE$1,500
- ExcelsiusGPS Robotic Navigation System$1,475
- Onvoy$1,294
- AMISTEM$1,182
How this compares
$158,128 in reported general payments places this provider in the 95th percentile of 319 orthopaedic surgery providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 427 | $9,319 |
| Tranexamic Acid | 144 | $8,323 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 421 | $5,110 |
| Cefadroxil | 330 | $2,396 |
| Tramadol Hcl | 437 | $2,218 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 132 | $1,609 |
| Diclofenac Sodium | 74 | $1,352 |
| Cephalexin | 189 | $855 |
| Methylprednisolone | 61 | $505 |
| Meloxicam | 116 | $478 |
| Gabapentin | 77 | $411 |
| Ondansetron OdtOndansetron | 36 | $393 |
| Ibuprofen | 21 | $276 |
| Cyclobenzaprine Hcl | 26 | $197 |
| Tizanidine Hcl | 44 | $181 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Mobile
- Joseph ZarzourMobile$68K
- Russell GoodeMobile$43K
- Jess MullensMobile$33K
- Clinton HowardMobile$24K
- Blake BowdenMobile$22K
- David DonahoeMobile$21K
- Albert HaasMobile$19K
- Jeffrey BrewerMobile$18K
- Robert HulickMobile$16K
- Jeffrey DugasBirmingham$11.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.